Fair Value Calculator Fair Value Calculator
EN DE

Reckitt Benckiser Group (RBGLY) Fair Value & Analysis

Consumer Defensive · US · Market cap $39.5B

RB Reckitt Benckiser Group logo Reckitt Benckiser Group RBGLY · US
Price$13.87
Fair Value$17.31
Upside+24.8%
Quality71/100
Watch Reckitt Benckiser Group for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range $10.94 – $29.03

Fair value as of: Jun 24, 2026

From 23 valuation models · updated 22 days ago

Fair value updated Jun 24, 2026, revised from $17.37 to $17.31 (−0.3%) since Jun 23, 2026. Share price +10.6% over the past month.

Price vs Fair Value (12 months)

$17.36 $12.13 Fair Value $17.31 Jul 2025 Jul 2026

12‑month range $12.13 – $17.36 · fair‑value band $10.94 – $29.03 · the $13.87 price screens below the $17.31 fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Reckitt Benckiser Group (RBGLY) currently trades at $13.87, while our model-based Fair Value estimate is $17.31, implying the stock looks roughly 24.8% undervalued today. We read business quality at 71/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Reckitt Benckiser Group generated revenue of $14.2B at a net margin of 22.4%. Revenue declined 2.6% year over year. It earns a return on equity of 44.2%. Net debt stands at $6.5B. Fundamentals as of Jun 24, 2026

Our scenario range runs from $10.94 (bear case) to $29.03 (bull case); at $13.87, the current price sits within that range. The share trades about 20% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -54% fair-value upside, at 25%, RBGLY screens cheaper than that median.

Key figures & financial health

Revenue (TTM) $14.2B
Revenue growth (YoY) -2.6%
Net margin 22.4%
Return on equity 44.2%
Free cash flow $1.7B FY2025
P/E ratio 9.5
More key figures
Operating margin 26.7%
EPS (TTM) $1.31
Dividend yield 4.7%
EPS growth (YoY) -13.2%
Net debt $6.5B FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

About the company

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva names; stain removal under Vanish brand name; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Reckitt Benckiser Group reported revenue of $13.9B in FY2025 versus $13.2B in FY2021, a compound +1.2%/yr. Reported net income was $3.1B in FY2025.

Revenue +1.2%/yr
FY21 $13.2B
FY22 $14.5B
FY23 $14.6B
FY24 $14.2B
FY25 $13.9B
Net income
FY21 −$32.0M
FY22 $2.3B
FY23 $1.6B
FY24 $1.4B
FY25 $3.1B

Is RBGLY fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Reckitt Benckiser Group Fair Value". https://www.fairvalue-calculator.com/stock/RBGLY

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PRG €123.42 €69.60 -44%
L'Oréal S.A LRLCF $450.56 $209.17 -54%
Unilever PLC UNA €50.99 €40.24 -21%
Colgate-Palmolive Company CL $88.67 $55.95 -37%
Hindustan Unilever Limited HINDUNILVR ₹2,160 ₹1,000 -54%
Kimberly-Clark Corporation KMBB34 R$530.90 R$72.97 -86%
Church & Dwight Co CHDC34 R$488.56 R$53.25 -89%
Essity AB ESSITYA kr 268.00 kr 265.76 -1%
Godrej Consumer Products Limited GODREJCP ₹998.00 ₹323.44 -68%
Marico Limited MARICO ₹819.90 ₹364.61 -56%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Reckitt Benckiser Group (RBGLY) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $17.31 versus a price of $13.87, about +25% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RBGLY?
Our model-based fair value for Reckitt Benckiser Group is $17.31 (as of Jun 24, 2026), built from audited fundamentals. The current price is $13.87.
What is the quality score of RBGLY?
Reckitt Benckiser Group has a Quality Score of 71/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Reckitt Benckiser Group (RBGLY)?
Reckitt Benckiser Group reported trailing-twelve-month revenue of about $14.2B (latest available figure, as of Jun 24, 2026).
What is the net profit margin of RBGLY?
The net profit margin of Reckitt Benckiser Group is about 22.4%, meaning it keeps roughly 22.4% of revenue as net income. Based on the latest reported figures.
Does Reckitt Benckiser Group pay a dividend?
Reckitt Benckiser Group currently shows a dividend yield of about 4.67% relative to its recent price (as of Jun 24, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

Free alert · no account needed

Tell me when Reckitt Benckiser Group reaches its Fair Value

Just your email, and we'll notify you when the price and Fair Value of Reckitt Benckiser Group materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.